NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues

The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MP. Molecular pathology 2001-04, Vol.54 (2), p.57-79
1. Verfasser: Perbal, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 79
container_issue 2
container_start_page 57
container_title MP. Molecular pathology
container_volume 54
creator Perbal, B
description The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.
doi_str_mv 10.1136/mp.54.2.57
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1187006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A75453322</galeid><sourcerecordid>A75453322</sourcerecordid><originalsourceid>FETCH-LOGICAL-b572t-8c776bb987bfa63bfbd676b99d86850e394526f4dfd0bf3c9ea5f03f75c413b93</originalsourceid><addsrcrecordid>eNp90l1v0zAUBuAIgdgY3PADUAQCAaLFTvyRcIE0RXxNU3cD0-6M7Ry3Hokd7GTa_j0urbohVSgXTuzHb46PnGVPMZpjXLL3_TCnZF7MKb-XHWLCixnBlNxP7yVjs4pjcpA9ivESIVSRonqYHaRtRYEZP8x-Ls7O89cOhlXwqpNx9L3M_RUEuB4CxAjtm1y6Nh9XkDfNIjeyt91N7k2-BAfxQx7HMOlxCrL768zk9Gi9S582xgni4-yBkV2EJ9vxKPvx-dP35uvs9OzLt-b4dKYoL8ZZpTlnStUVV0ayUhnVsjRR123FKoqgrAktmCGtaZEypa5BUoNKw6kmuFR1eZR93OQOk-qh1eDGVJMYgu1luBFeWvHvirMrsfRXAuOKI8RSwKttQPC_U-Gj6G3U0HXSgZ-i4IjXNUZlgs83cCk7ENYZn_L0GotjTgktU28TercHrXuW_u0dGJum7_LZHp6eFnqr9_m3G6-DjzGA2R0UI7G-FKIfBCWiEJQn_Oxua27p9hYk8GILZNSyM0E6bePO1YTUBN3WaOMI17tVGX6JlMGpWJw3YnFxgU4aRsRJ8i83XvWX_yvvD4-_2hI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70799103</pqid></control><display><type>article</type><title>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Perbal, B</creator><creatorcontrib>Perbal, B</creatorcontrib><description>The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.</description><identifier>ISSN: 1366-8714</identifier><identifier>EISSN: 1472-4154</identifier><identifier>DOI: 10.1136/mp.54.2.57</identifier><identifier>PMID: 11322167</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>angiogenesis ; Animals ; Biological and medical sciences ; Cancer ; Carcinogenesis, carcinogens and anticarcinogens ; CCN ; Cell differentiation ; Connective Tissue Growth Factor ; ctgf ; cyr61 ; development ; differentiation ; fibrosis ; Gene Expression Regulation, Neoplastic ; General aspects ; Genetic aspects ; Growth Substances - genetics ; Growth Substances - metabolism ; Humans ; Immediate-Early Proteins ; Intercellular Signaling Peptides and Proteins ; Medical sciences ; Methods ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Neoplasms - genetics ; Neoplasms - metabolism ; Neovascularization ; Nephroblastoma ; Nephroblastoma Overexpressed Protein ; Oncogene Proteins, Viral - genetics ; Oncogene Proteins, Viral - metabolism ; Oncology ; Pathology, Molecular ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Review ; RNA, Neoplasm - genetics ; signalling ; Tumors ; wisp</subject><ispartof>MP. Molecular pathology, 2001-04, Vol.54 (2), p.57-79</ispartof><rights>COPYRIGHT © 2001 Journal of Clinical Pathology</rights><rights>2001 INIST-CNRS</rights><rights>COPYRIGHT 2001 BMJ Publishing Group Ltd.</rights><rights>Copyright © 2001, Journal of Clinical Pathology 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b572t-8c776bb987bfa63bfbd676b99d86850e394526f4dfd0bf3c9ea5f03f75c413b93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187006/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187006/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,309,310,314,727,780,784,789,790,885,23930,23931,25140,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=944940$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11322167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perbal, B</creatorcontrib><title>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</title><title>MP. Molecular pathology</title><addtitle>Mol Path</addtitle><description>The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.</description><subject>angiogenesis</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>CCN</subject><subject>Cell differentiation</subject><subject>Connective Tissue Growth Factor</subject><subject>ctgf</subject><subject>cyr61</subject><subject>development</subject><subject>differentiation</subject><subject>fibrosis</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>General aspects</subject><subject>Genetic aspects</subject><subject>Growth Substances - genetics</subject><subject>Growth Substances - metabolism</subject><subject>Humans</subject><subject>Immediate-Early Proteins</subject><subject>Intercellular Signaling Peptides and Proteins</subject><subject>Medical sciences</subject><subject>Methods</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - metabolism</subject><subject>Neovascularization</subject><subject>Nephroblastoma</subject><subject>Nephroblastoma Overexpressed Protein</subject><subject>Oncogene Proteins, Viral - genetics</subject><subject>Oncogene Proteins, Viral - metabolism</subject><subject>Oncology</subject><subject>Pathology, Molecular</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Review</subject><subject>RNA, Neoplasm - genetics</subject><subject>signalling</subject><subject>Tumors</subject><subject>wisp</subject><issn>1366-8714</issn><issn>1472-4154</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90l1v0zAUBuAIgdgY3PADUAQCAaLFTvyRcIE0RXxNU3cD0-6M7Ry3Hokd7GTa_j0urbohVSgXTuzHb46PnGVPMZpjXLL3_TCnZF7MKb-XHWLCixnBlNxP7yVjs4pjcpA9ivESIVSRonqYHaRtRYEZP8x-Ls7O89cOhlXwqpNx9L3M_RUEuB4CxAjtm1y6Nh9XkDfNIjeyt91N7k2-BAfxQx7HMOlxCrL768zk9Gi9S582xgni4-yBkV2EJ9vxKPvx-dP35uvs9OzLt-b4dKYoL8ZZpTlnStUVV0ayUhnVsjRR123FKoqgrAktmCGtaZEypa5BUoNKw6kmuFR1eZR93OQOk-qh1eDGVJMYgu1luBFeWvHvirMrsfRXAuOKI8RSwKttQPC_U-Gj6G3U0HXSgZ-i4IjXNUZlgs83cCk7ENYZn_L0GotjTgktU28TercHrXuW_u0dGJum7_LZHp6eFnqr9_m3G6-DjzGA2R0UI7G-FKIfBCWiEJQn_Oxua27p9hYk8GILZNSyM0E6bePO1YTUBN3WaOMI17tVGX6JlMGpWJw3YnFxgU4aRsRJ8i83XvWX_yvvD4-_2hI</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Perbal, B</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>British Medical Journal Publishing Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010401</creationdate><title>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</title><author>Perbal, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b572t-8c776bb987bfa63bfbd676b99d86850e394526f4dfd0bf3c9ea5f03f75c413b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>angiogenesis</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>CCN</topic><topic>Cell differentiation</topic><topic>Connective Tissue Growth Factor</topic><topic>ctgf</topic><topic>cyr61</topic><topic>development</topic><topic>differentiation</topic><topic>fibrosis</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>General aspects</topic><topic>Genetic aspects</topic><topic>Growth Substances - genetics</topic><topic>Growth Substances - metabolism</topic><topic>Humans</topic><topic>Immediate-Early Proteins</topic><topic>Intercellular Signaling Peptides and Proteins</topic><topic>Medical sciences</topic><topic>Methods</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - metabolism</topic><topic>Neovascularization</topic><topic>Nephroblastoma</topic><topic>Nephroblastoma Overexpressed Protein</topic><topic>Oncogene Proteins, Viral - genetics</topic><topic>Oncogene Proteins, Viral - metabolism</topic><topic>Oncology</topic><topic>Pathology, Molecular</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Review</topic><topic>RNA, Neoplasm - genetics</topic><topic>signalling</topic><topic>Tumors</topic><topic>wisp</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perbal, B</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>MP. Molecular pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perbal, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues</atitle><jtitle>MP. Molecular pathology</jtitle><addtitle>Mol Path</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>54</volume><issue>2</issue><spage>57</spage><epage>79</epage><pages>57-79</pages><issn>1366-8714</issn><eissn>1472-4154</eissn><abstract>The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>11322167</pmid><doi>10.1136/mp.54.2.57</doi><tpages>23</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1366-8714
ispartof MP. Molecular pathology, 2001-04, Vol.54 (2), p.57-79
issn 1366-8714
1472-4154
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1187006
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects angiogenesis
Animals
Biological and medical sciences
Cancer
Carcinogenesis, carcinogens and anticarcinogens
CCN
Cell differentiation
Connective Tissue Growth Factor
ctgf
cyr61
development
differentiation
fibrosis
Gene Expression Regulation, Neoplastic
General aspects
Genetic aspects
Growth Substances - genetics
Growth Substances - metabolism
Humans
Immediate-Early Proteins
Intercellular Signaling Peptides and Proteins
Medical sciences
Methods
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Neoplasms - genetics
Neoplasms - metabolism
Neovascularization
Nephroblastoma
Nephroblastoma Overexpressed Protein
Oncogene Proteins, Viral - genetics
Oncogene Proteins, Viral - metabolism
Oncology
Pathology, Molecular
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Review
RNA, Neoplasm - genetics
signalling
Tumors
wisp
title NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A51%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NOV%20(nephroblastoma%20overexpressed)%20and%20the%20CCN%20family%20of%20genes:%20structural%20and%20functional%20issues&rft.jtitle=MP.%20Molecular%20pathology&rft.au=Perbal,%20B&rft.date=2001-04-01&rft.volume=54&rft.issue=2&rft.spage=57&rft.epage=79&rft.pages=57-79&rft.issn=1366-8714&rft.eissn=1472-4154&rft_id=info:doi/10.1136/mp.54.2.57&rft_dat=%3Cgale_pubme%3EA75453322%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70799103&rft_id=info:pmid/11322167&rft_galeid=A75453322&rfr_iscdi=true